Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Allena announces completion of enrollment of cohorts A, B of ALLN-346 » 08:03
07/19/22
07/19
08:03
07/19/22
08:03
ALNA

Allena Pharmaceuticals

/

+

Allena Pharmaceuticals…

Allena Pharmaceuticals reported completion of enrollment of the first two cohorts of its ALLN-346 Phase 2a Study 202 in gout patients with stage 2 and stage 3 chronic kidney disease, CKD. ALLN-346 is a bio-engineered enzyme specifically designed to degrade urate in the gastrointestinal tract without systemic absorption and thereby reduce systemic urate levels in patients with hyperuricemia, gout and CKD. Cohort A has enrolled seven patients with an estimated glomerular filtration rate and Cohort B has enrolled twelve patients with an eGFR. David Clark, M.D., M.R.C.P., Chief Medical Officer of Allena Pharmaceuticals, Inc., stated, "We are pleased with the progress of our ALLN-346 Phase 2a program, and thank our patients, investigators and business partners for helping us achieve this operational milestone. This is an important step in our efforts to develop a new treatment option for patients with hyperuricemia, gout and advanced CKD. There is an established pathophysiologic adaptation of increased intestinal elimination of uric acid in patients with impaired kidney function, so we believe the ALLN-346 therapeutic strategy of degrading uric acid in the GI tract is based on a strong scientific rationale. We have been encouraged by initial data from Study 201, which have provided evidence supporting the GI mechanism of action for ALLN-346, including the positive correlation between serum uric acid reduction and the degree of renal impairment. We look forward to reporting additional topline safety and efficacy data from the cohorts thus far enrolled in the ALLN-346 Phase 2a development program later this quarter."

ShowHide Related Items >><<
ALNA Allena Pharmaceuticals
/

+

ALNA Allena Pharmaceuticals
/

+

03/22/22 B. Riley
Allena Pharmaceuticals downgraded on financing overhang at B. Riley
03/21/22 B. Riley
Allena Pharmaceuticals downgraded to Neutral from Buy at B. Riley
03/21/22 H.C. Wainwright
H.C. Wainwright downgrades Allena on reloxaliase discontinuation
03/21/22 H.C. Wainwright
Allena Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
ALNA Allena Pharmaceuticals
/

+

Over a month ago
Hot Stocks
Allena reschedules special meeting to approve reverse stock split » 07:09
07/05/22
07/05
07:09
07/05/22
07:09
ALNA

Allena Pharmaceuticals

/

+

Allena Pharmaceuticals…

Allena Pharmaceuticals announced that it has rescheduled its special meeting, which was scheduled for July 5, 2022, to, among other things, consider and vote on a proposed amendment to its amended and restated certificate of incorporation, as amended, in order to effect a reverse stock split of its issued and outstanding common stock. The date of the rescheduled special meeting, and the new record date for determining the Allena stockholders entitled to vote thereat, will be determined in the near future, and will be will be included in supplemental proxy materials to be filed with the SEC and distributed to stockholders promptly after the new record date.

ShowHide Related Items >><<
ALNA Allena Pharmaceuticals
/

+

ALNA Allena Pharmaceuticals
/

+

03/22/22 B. Riley
Allena Pharmaceuticals downgraded on financing overhang at B. Riley
03/21/22 B. Riley
Allena Pharmaceuticals downgraded to Neutral from Buy at B. Riley
03/21/22 H.C. Wainwright
H.C. Wainwright downgrades Allena on reloxaliase discontinuation
03/21/22 H.C. Wainwright
Allena Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
ALNA Allena Pharmaceuticals
/

+

Syndicate
Allena Pharmaceuticals files to sell common stock, warrants, no amount given » 16:47
06/23/22
06/23
16:47
06/23/22
16:47
ALNA

Allena Pharmaceuticals

/

+

H.C. Wainwright & Co.…

H.C. Wainwright & Co. is managing the offering.

ShowHide Related Items >><<
ALNA Allena Pharmaceuticals
/

+

ALNA Allena Pharmaceuticals
/

+

03/22/22 B. Riley
Allena Pharmaceuticals downgraded on financing overhang at B. Riley
03/21/22 B. Riley
Allena Pharmaceuticals downgraded to Neutral from Buy at B. Riley
03/21/22 H.C. Wainwright
H.C. Wainwright downgrades Allena on reloxaliase discontinuation
03/21/22 H.C. Wainwright
Allena Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
ALNA Allena Pharmaceuticals
/

+

Over a quarter ago
Hot Stocks
Allena Pharmaceuticals announces $2.8M registered direct offering » 08:12
05/04/22
05/04
08:12
05/04/22
08:12
ALNA

Allena Pharmaceuticals

/

+

Allena Pharmaceuticals…

Allena Pharmaceuticals announced that it has entered into a securities purchase agreement with an investor for the issuance and sale of an aggregate of 1,436.0688 shares of its Series D Convertible Preferred Stock, and 1,436.0688 shares of its Series E Convertible Preferred Stock in a registered direct offering for an aggregate gross proceeds of approximately $2.8 million, before deducting placement agent fees and other offering expenses. The shares of Series D Convertible Preferred Stock and Series E Convertible Preferred Stock each have a stated value of $1,000 per share and are convertible into an aggregate of 8,975,430 shares of common stock of the Company upon the conversion of the Series D Convertible Preferred Stock and into an aggregate of 8,975,430 shares of common stock of the Company upon the conversion of the Series E Convertible Preferred Stock, in each case, at a conversion price of $0.16 per share. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The Company has declared a record date of May 4, 2022 for a special meeting of stockholders for the approval of a proposal to effect a reverse split of its common stock. The Series D Convertible Preferred Stock has voting rights on the Proposal equal to the number of shares of common stock into which the Series D Convertible Preferred Stock is convertible based on a price of $0.1693 per share, per Nasdaq voting requirements. The Series E Convertible Preferred Stock has voting rights on the Proposal equal to 1,000,000 votes per share of Series E Convertible Preferred Stock, provided that, in accordance with Nasdaq listing rules, any votes cast by the Series E Convertible Preferred Stock with respect to the Proposal must be counted by the Company in the same proportion as the shares of common stock and Series D Convertible Preferred Stock that voted on the Proposal. The shares of the Series D Convertible Preferred Stock and Series E Convertible Preferred Stock are convertible at the option of the holder at any time following the date of issuance. The closing of the offering is expected to occur on May 4, 2022, subject to the satisfaction of customary closing conditions. Allena currently intends to use the net proceeds from the offering for working capital purposes which may include repayment of debt. In a concurrent private placement, the Company also agreed to issue to the investor in the registered direct offering unregistered warrants to purchase up to an aggregate of 22,438,575 shares of our common stock, at an exercise price of $0.1694 per share, which are exercisable six months following the date of issuance, and will expire five years from the initial exercise date.

ShowHide Related Items >><<
ALNA Allena Pharmaceuticals
/

+

ALNA Allena Pharmaceuticals
/

+

03/22/22 B. Riley
Allena Pharmaceuticals downgraded on financing overhang at B. Riley
03/21/22 B. Riley
Allena Pharmaceuticals downgraded to Neutral from Buy at B. Riley
03/21/22 H.C. Wainwright
H.C. Wainwright downgrades Allena on reloxaliase discontinuation
03/21/22 H.C. Wainwright
Allena Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
ALNA Allena Pharmaceuticals
/

+

ALNA Allena Pharmaceuticals
/

+

Downgrade
Allena Pharmaceuticals downgraded on financing overhang at B. Riley » 08:19
03/22/22
03/22
08:19
03/22/22
08:19
ALNA

Allena Pharmaceuticals

/

+

B. Riley analyst Mayank…

B. Riley analyst Mayank Mamtani last night downgraded Allena Pharmaceuticals to Neutral from Buy with a price target of 50c, down from $3, after the company disclosed the discontinuation of further clinical development activity of its lead program, reloxaliase, in patients with enteric hyperoxaluria. The company's financing "overhang" limits the potential of its early-stage gout drug, Mamtani As previously reported,

ShowHide Related Items >><<
ALNA Allena Pharmaceuticals
/

+

ALNA Allena Pharmaceuticals
/

+

03/21/22 B. Riley
Allena Pharmaceuticals downgraded to Neutral from Buy at B. Riley
03/21/22 H.C. Wainwright
H.C. Wainwright downgrades Allena on reloxaliase discontinuation
03/21/22 H.C. Wainwright
Allena Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
03/21/22 Ladenburg
Allena Pharmaceuticals downgraded to Neutral from Buy at Ladenburg
ALNA Allena Pharmaceuticals
/

+

ALNA Allena Pharmaceuticals
/

+

On The Fly
What You Missed On Wall Street On Monday » 16:33
03/21/22
03/21
16:33
03/21/22
16:33
PLAN

Acquired by Thoma Bravo 6/22

$64.60 /

+13.99 (+27.64%)

, BRK.A

Berkshire Hathaway

$524,185.00 /

+11525 (+2.25%)

, BRK.B

Berkshire Hathaway

$349.67 /

+7.28 (+2.13%)

, Y

Alleghany

$844.45 /

+172.95 (+25.76%)

, NLSN

Nielsen

$22.75 /

-1.69 (-6.91%)

, GM

General Motors

$43.62 /

-1.195 (-2.67%)

, SFTBF

Use SFTBY

$41.10 /

-2.14 (-4.95%)

, KSS

Kohl's

$61.99 /

-0.43 (-0.69%)

, GS

Goldman Sachs

$339.09 /

-6.475 (-1.87%)

, IMGN

ImmunoGen

$4.30 /

-0.95 (-18.10%)

, CHKP

Check Point

$136.81 /

-3.41 (-2.43%)

, DUOL

Duolingo

$89.73 /

+0.65 (+0.73%)

, IAS

Integral Ad Science

$15.73 /

+1.16 (+7.96%)

, DDL

Dingdong

$3.42 /

-0.31 (-8.31%)

, BA

Boeing

$185.97 /

-6.94 (-3.60%)

, HNHPF

Hon Hai Precision

$7.32 /

-0.12 (-1.61%)

, CEA

China Eastern Airlines

$17.69 /

-1.22 (-6.45%)

, CVX

Chevron

$164.64 /

+4.03 (+2.51%)

, AMZN

Amazon.com

$3,230.56 /

+1.98 (+0.06%)

, SWCH

Switch

$29.44 /

+0.66 (+2.29%)

, OXY

Occidental Petroleum

$60.96 /

+4.72 (+8.39%)

, ALNA

Allena Pharmaceuticals

/

+

, GEVO

Gevo

$4.59 /

+0.28 (+6.50%)

, COIN

Coinbase

$176.78 /

-9.03 (-4.86%)

, VLTA

Volta

$4.12 /

-0.35 (-7.83%)

, PDD

Pinduoduo

$39.93 /

-2.61 (-6.14%)

, GRPH

Graphite Bio

$6.83 /

-1.38 (-16.81%)

, MRNS

Marinus Pharmaceuticals

$8.67 /

-1.31 (-13.13%)

, URGN

UroGen Pharma

$9.05 /

+0.08 (+0.89%)

, CLRB

Cellectar Biosciences

/

+

Get caught up quickly on…

ShowHide Related Items >><<
Y Alleghany
$844.45 /

+172.95 (+25.76%)

VLTA Volta
$4.12 /

-0.35 (-7.83%)

URGN UroGen Pharma
$9.05 /

+0.08 (+0.89%)

SWCH Switch
$29.44 /

+0.66 (+2.29%)

PLAN Acquired by Thoma Bravo 6/22
$64.60 /

+13.99 (+27.64%)

PDD Pinduoduo
$39.93 /

-2.61 (-6.14%)

OXY Occidental Petroleum
$60.96 /

+4.72 (+8.39%)

NLSN Nielsen
$22.75 /

-1.69 (-6.91%)

MRNS Marinus Pharmaceuticals
$8.67 /

-1.31 (-13.13%)

KSS Kohl's
$61.99 /

-0.43 (-0.69%)

IMGN ImmunoGen
$4.30 /

-0.95 (-18.10%)

IAS Integral Ad Science
$15.73 /

+1.16 (+7.96%)

HNHPF Hon Hai Precision
$7.32 /

-0.12 (-1.61%)

GS Goldman Sachs
$339.09 /

-6.475 (-1.87%)

GRPH Graphite Bio
$6.83 /

-1.38 (-16.81%)

GM General Motors
$43.62 /

-1.195 (-2.67%)

GEVO Gevo
$4.59 /

+0.28 (+6.50%)

DUOL Duolingo
$89.73 /

+0.65 (+0.73%)

DDL Dingdong
$3.42 /

-0.31 (-8.31%)

CVX Chevron
$164.64 /

+4.03 (+2.51%)

COIN Coinbase
$176.78 /

-9.03 (-4.86%)

CLRB Cellectar Biosciences
/

+

CHKP Check Point
$136.81 /

-3.41 (-2.43%)

CEA China Eastern Airlines
$17.69 /

-1.22 (-6.45%)

BRK.B Berkshire Hathaway
$349.67 /

+7.28 (+2.13%)

BRK.A Berkshire Hathaway
$524,185.00 /

+11525 (+2.25%)

BA Boeing
$185.97 /

-6.94 (-3.60%)

AMZN Amazon.com
$3,230.56 /

+1.98 (+0.06%)

ALNA Allena Pharmaceuticals
/

+

PLAN Acquired by Thoma Bravo 6/22
$64.60 /

+13.99 (+27.64%)

03/21/22 Wells Fargo
Anaplan downgraded to Equal Weight from Overweight at Wells Fargo
03/21/22 BMO Capital
Anaplan price target raised to $66 from $55 at BMO Capital
03/21/22 William Blair
Anaplan downgraded to Market Perform from Outperform at William Blair
03/21/22 Wolfe Research
Anaplan downgraded to Peer Perform from Outperform at Wolfe Research
BRK.A Berkshire Hathaway
$524,185.00 /

+11525 (+2.25%)

03/21/22 Keefe Bruyette
Alleghany complexity makes other bids unlikely, says Keefe Bruyette
11/07/21 Keefe Bruyette
Berkshire Q3 missed 'virtually across the board,' says Keefe Bruyette
09/07/21 Wells Fargo
Kroger price target raised to $46 from $39 at Wells Fargo
06/24/21 Gordon Haskett
Hershey jet found recently in Omaha, says Gordon Haskett
BRK.B Berkshire Hathaway
$349.67 /

+7.28 (+2.13%)

08/09/21 UBS
Berkshire Hathaway price target raised to $329 from $319 at UBS
Y Alleghany
$844.45 /

+172.95 (+25.76%)

03/20/22 Keefe Bruyette
Alleghany initiated with an Outperform at Keefe Bruyette
08/06/21 Deutsche Bank
Alleghany price target raised to $915 from $890 at Deutsche Bank
05/07/21 Deutsche Bank
Alleghany price target raised to $890 from $825 at Deutsche Bank
NLSN Nielsen
$22.75 /

-1.69 (-6.91%)

03/15/22 Baird
Nielsen price target raised to $25 from $20 at Baird
03/08/22 Citi
Nielsen price target lowered to $19 from $21 at Citi
01/27/22 Truist
Truist downgrades Nielsen on competition in TV measurement
01/27/22 Truist
Nielsen downgraded to Hold from Buy at Truist
GM General Motors
$43.62 /

-1.195 (-2.67%)

03/22/22 RBC Capital
Cepton initiated with a Sector Perform at RBC Capital
03/21/22 Morgan Stanley
General Motors' EV/AV valuation cut by 'nearly half' at Morgan Stanley
03/21/22 Wolfe Research
General Motors price target raised to $70 from $67 at Wolfe Research
03/16/22 Craig-Hallum
Craig-Hallum starts 'lidar's new leader' Cepton at Buy
SFTBF Use SFTBY
$41.10 /

-2.14 (-4.95%)

KSS Kohl's
$61.99 /

-0.43 (-0.69%)

03/08/22 Credit Suisse
Kohl's price target lowered to $60 from $70 at Credit Suisse
03/08/22 Citi
Kohl's investors wanted to hear more about sale, says Citi
03/08/22 BofA
Kohl's reinstated with a Neutral at BofA
03/02/22 Baird
Kohl's price target lowered to $68 from $75 at Baird
GS Goldman Sachs
$339.09 /

-6.475 (-1.87%)

02/01/22 Piper Sandler
Piper Sandler names favorite financial services stocks post Q4 results
01/28/22 Odeon Capital
Morgan Stanley cut to Hold at Odeon Capital on Fed balance sheet plans
01/28/22 Odeon Capital
Goldman Sachs cut to Hold at Odeon Capital on Fed balance sheet plans
01/28/22 Odeon Capital
Goldman Sachs downgraded to Hold from Buy at Odeon Capital
IMGN ImmunoGen
$4.30 /

-0.95 (-18.10%)

03/21/22 RBC Capital
ImmunoGen downgraded to Sector Perform from Outperform at RBC Capital
02/10/22 BMO Capital
ImmunoGen initiated with an Outperform at BMO Capital
01/03/22 Guggenheim
ImmunoGen, Merus named 'Best Ideas' in oncology-focused biotech at Guggenheim
12/01/21 Jefferies
ImmunoGen upgraded to Buy at Jefferies after 'best-case data' in PROC
CHKP Check Point
$136.81 /

-3.41 (-2.43%)

03/21/22 Piper Sandler
Check Point downgraded to Underweight from Neutral at Piper Sandler
03/17/22 Deutsche Bank
Check Point price target raised to $160 from $154 at Deutsche Bank
03/10/22 Cowen
Check Point price target raised to $164 from $142 at Cowen
02/16/22 BMO Capital
Check Point upgraded to Outperform from Market Perform at BMO Capital
DUOL Duolingo
$89.73 /

+0.65 (+0.73%)

03/21/22 KeyBanc
KeyBanc upgrades Duolingo to Overweight with $112 price target
03/21/22 KeyBanc
Duolingo upgraded to Overweight from Sector Weight at KeyBanc
03/15/22 Evercore ISI
Duolingo, XPO Logistics added to 'Best SMID 'Core' Ideas' list at Evercore ISI
03/04/22 Evercore ISI
Duolingo removed from 'Tactical Outperform' list, target cut to $120 at Evercore
IAS Integral Ad Science
$15.73 /

+1.16 (+7.96%)

03/21/22 Raymond James
Integral Ad Science upgraded at Raymond James amid 'unjustified' selloff
03/21/22 Raymond James
Integral Ad Science upgraded to Strong Buy from Outperform at Raymond James
03/17/22 Barclays
Barclays says Meta opening up feed positive for DoubleVerify, Integral Ad
03/04/22 Barclays
Integral Ad Science price target lowered to $20 from $23 at Barclays
DDL Dingdong
$3.42 /

-0.31 (-8.31%)

03/21/22 Morgan Stanley
Dingdong downgraded to Underweight from Overweight at Morgan Stanley
03/14/22 JPMorgan
JPMorgan downgrades Dada Nexus to Neutral, prefers over smaller peer Dingdong
03/14/22 JPMorgan
Dingdong price target lowered to $2.50 from $21 at JPMorgan
11/19/21 JPMorgan
Dingdong initiated with an Underweight at JPMorgan
BA Boeing
$185.97 /

-6.94 (-3.60%)

03/21/22 JPMorgan
Chinese government response to 737 crash critical for Boeing, says JPMorgan
03/16/22 Baird
Boeing elevated to Bullish Fresh Pick at Baird
03/09/22
Boeing initiated with a Buy rating at Langenberg
03/07/22 Cowen
Boeing price target lowered to $230 from $265 at Cowen
HNHPF Hon Hai Precision
$7.32 /

-0.12 (-1.61%)

03/14/22 BofA
Apple exposure to Shenzhen and Suzhou 'manageable,' says BofA
11/12/21 R.F. Lafferty
R.F. Lafferty upgrades Lordstown to Hold on better odds for Endurance production
CEA China Eastern Airlines
$17.69 /

-1.22 (-6.45%)

03/15/22 Credit Suisse
China Eastern Airlines downgraded to Underperform from Neutral at Credit Suisse
02/08/22 Goldman Sachs
China Eastern Airlines initiated with a Buy at Goldman Sachs
11/29/21 JPMorgan
China Eastern Airlines downgraded to Neutral from Overweight at JPMorgan
07/30/21 JPMorgan
China Eastern Airlines downgraded to Neutral from Overweight at JPMorgan
CVX Chevron
$164.64 /

+4.03 (+2.51%)

03/14/22 Morgan Stanley
Chevron downgraded to Equal Weight at Morgan Stanley after outperformance
03/14/22 Morgan Stanley
Chevron downgraded to Equal Weight from Overweight at Morgan Stanley
03/11/22 JPMorgan
Chevron downgraded to Underweight from Neutral at JPMorgan
03/09/22 Barclays
Chevron price target raised to $183 from $148 at Barclays
AMZN Amazon.com
$3,230.56 /

+1.98 (+0.06%)

03/21/22 CL King
SpartanNash initiated with a Neutral at CL King
03/16/22 Needham
Needham says Netflix needs ads as streamers turn to news, sports
03/15/22 BWS Financial
BWS drops coverage of PLx Pharma, says off Amazon again
03/10/22 Deutsche Bank
Amazon.com initiated with a Buy at Deutsche Bank
SWCH Switch
$29.44 /

+0.66 (+2.29%)

03/04/22 Cowen
Switch could yield $30 per share in potential LBO scenario, says Cowen
01/14/22 Barclays
Switch price target raised to $30 from $28 at Barclays
01/11/22 Citi
Citi adds Crown Castle, Switch to 'Positive Catalyst Watch List'
12/16/21 RBC Capital
Switch initiated with an Outperform at RBC Capital
OXY Occidental Petroleum
$60.96 /

+4.72 (+8.39%)

03/18/22 Barclays
Occidental Petroleum price target raised to $69 from $44 at Barclays
03/14/22 Morgan Stanley
Occidental Petroleum downgraded to Equal Weight at Morgan Stanley after doubling
03/14/22 Morgan Stanley
Occidental downgraded to Equal Weight from Overweight at Morgan Stanley
03/11/22 Truist
Occidental Petroleum price target raised to $75 from $58 at Truist
ALNA Allena Pharmaceuticals
/

+

03/21/22 B. Riley
Allena Pharmaceuticals downgraded to Neutral from Buy at B. Riley
03/21/22 H.C. Wainwright
H.C. Wainwright downgrades Allena on reloxaliase discontinuation
03/21/22 H.C. Wainwright
Allena Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
03/21/22 Ladenburg
Allena Pharmaceuticals downgraded to Neutral from Buy at Ladenburg
GEVO Gevo
$4.59 /

+0.28 (+6.50%)

02/09/22 Citi
Gevo initiated with a Buy at Citi
08/23/21 Stifel
Gevo initiated with a Buy, $10 price target at Stifel
08/23/21 Stifel
Gevo initiated with a Buy at Stifel
COIN Coinbase
$176.78 /

-9.03 (-4.86%)

03/22/22 Citi
Coinbase price target lowered to $275 from $300 at Citi
02/28/22 Compass Point
Coinbase price target lowered to $200 from $325 at Compass Point
02/25/22 Needham
Coinbase price target lowered to $360 from $420 at Needham
02/25/22 Canaccord
Coinbase price target lowered to $275 from $342 at Canaccord
VLTA Volta
$4.12 /

-0.35 (-7.83%)

02/01/22 Canaccord
Volta initiated with a Buy, $10 target at Canaccord
02/01/22 Canaccord
Volta initiated with a Buy at Canaccord
12/15/21 Goldman Sachs
Volta initiated with a Neutral at Goldman Sachs
12/14/21 Cantor Fitzgerald
Cantor starts Volta at Overweight with $13 price target
PDD Pinduoduo
$39.93 /

-2.61 (-6.14%)

03/22/22 Benchmark
Pinduoduo price target lowered to $85 from $156 at Benchmark
03/22/22 Citi
Pinduoduo price target lowered to $61 from $80 at Citi
03/22/22 Nomura
Pinduoduo downgraded to Neutral from Buy at Nomura
03/22/22 HSBC
Pinduoduo price target lowered to $46 from $76 at HSBC
GRPH Graphite Bio
$6.83 /

-1.38 (-16.81%)

03/21/22 Morgan Stanley
Graphite Bio downgraded to Equal Weight from Overweight at Morgan Stanley
02/17/22 RBC Capital
RBC starts Graphite Bio at Sector Perform, sees limited conviction on lead asset
02/17/22 RBC Capital
Graphite Bio initiated with a Sector Perform at RBC Capital
07/20/21 Cowen
Cowen starts Graphite Bio at Outperform, sees long-term value
MRNS Marinus Pharmaceuticals
$8.67 /

-1.31 (-13.13%)

02/23/22 Truist
Marinus Pharmaceuticals price target lowered to $35 from $40 at Truist
08/18/21 Truist
Marinus Pharmaceuticals price target raised to $40 from $35 at Truist
URGN UroGen Pharma
$9.05 /

+0.08 (+0.89%)

03/22/22 H.C. Wainwright
UroGen Pharma price target lowered to $26 from $34 at H.C. Wainwright
01/18/22 H.C. Wainwright
UroGen Pharma price target lowered to $34 from $50 at H.C. Wainwright
04/27/21 H.C. Wainwright
UroGen Pharma price target lowered to $50 from $57 at H.C. Wainwright
CLRB Cellectar Biosciences
/

+

08/16/21 Roth Capital
Roth Capital views Cellectar Biosciences as 'grossly undervalued'
06/04/21 Roth Capital
Cellectar Biosciences' Phase 2a results 'highly positive,' says Roth Capital
04/27/21 Roth Capital
Cellectar strengthens IP estate as CLR 131 trial progresses, says Roth Capital
Y Alleghany
$844.45 /

+172.95 (+25.76%)

VLTA Volta
$4.12 /

-0.35 (-7.83%)

URGN UroGen Pharma
$9.05 /

+0.08 (+0.89%)

SWCH Switch
$29.44 /

+0.66 (+2.29%)

PLAN Acquired by Thoma Bravo 6/22
$64.60 /

+13.99 (+27.64%)

PDD Pinduoduo
$39.93 /

-2.61 (-6.14%)

OXY Occidental Petroleum
$60.96 /

+4.72 (+8.39%)

NLSN Nielsen
$22.75 /

-1.69 (-6.91%)

MRNS Marinus Pharmaceuticals
$8.67 /

-1.31 (-13.13%)

KSS Kohl's
$61.99 /

-0.43 (-0.69%)

IMGN ImmunoGen
$4.30 /

-0.95 (-18.10%)

IAS Integral Ad Science
$15.73 /

+1.16 (+7.96%)

GS Goldman Sachs
$339.09 /

-6.475 (-1.87%)

GRPH Graphite Bio
$6.83 /

-1.38 (-16.81%)

GM General Motors
$43.62 /

-1.195 (-2.67%)

GEVO Gevo
$4.59 /

+0.28 (+6.50%)

DUOL Duolingo
$89.73 /

+0.65 (+0.73%)

CVX Chevron
$164.64 /

+4.03 (+2.51%)

COIN Coinbase
$176.78 /

-9.03 (-4.86%)

CLRB Cellectar Biosciences
/

+

CHKP Check Point
$136.81 /

-3.41 (-2.43%)

BRK.A Berkshire Hathaway
$524,185.00 /

+11525 (+2.25%)

BA Boeing
$185.97 /

-6.94 (-3.60%)

AMZN Amazon.com
$3,230.56 /

+1.98 (+0.06%)

ALNA Allena Pharmaceuticals
/

+

  • 02
    Dec
  • 28
    Jul
  • 29
    Jun
  • 30
    Jun
  • 25
    Jun
  • 14
    Apr
VLTA Volta
$4.12 /

-0.35 (-7.83%)

SWCH Switch
$29.44 /

+0.66 (+2.29%)

PLAN Acquired by Thoma Bravo 6/22
$64.60 /

+13.99 (+27.64%)

PDD Pinduoduo
$39.93 /

-2.61 (-6.14%)

OXY Occidental Petroleum
$60.96 /

+4.72 (+8.39%)

NLSN Nielsen
$22.75 /

-1.69 (-6.91%)

KSS Kohl's
$61.99 /

-0.43 (-0.69%)

HNHPF Hon Hai Precision
$7.32 /

-0.12 (-1.61%)

GS Goldman Sachs
$339.09 /

-6.475 (-1.87%)

GM General Motors
$43.62 /

-1.195 (-2.67%)

GEVO Gevo
$4.59 /

+0.28 (+6.50%)

DDL Dingdong
$3.42 /

-0.31 (-8.31%)

CVX Chevron
$164.64 /

+4.03 (+2.51%)

COIN Coinbase
$176.78 /

-9.03 (-4.86%)

CHKP Check Point
$136.81 /

-3.41 (-2.43%)

BRK.B Berkshire Hathaway
$349.67 /

+7.28 (+2.13%)

BRK.A Berkshire Hathaway
$524,185.00 /

+11525 (+2.25%)

BA Boeing
$185.97 /

-6.94 (-3.60%)

AMZN Amazon.com
$3,230.56 /

+1.98 (+0.06%)

VLTA Volta
$4.12 /

-0.35 (-7.83%)

SWCH Switch
$29.44 /

+0.66 (+2.29%)

PLAN Acquired by Thoma Bravo 6/22
$64.60 /

+13.99 (+27.64%)

OXY Occidental Petroleum
$60.96 /

+4.72 (+8.39%)

NLSN Nielsen
$22.75 /

-1.69 (-6.91%)

KSS Kohl's
$61.99 /

-0.43 (-0.69%)

IMGN ImmunoGen
$4.30 /

-0.95 (-18.10%)

HNHPF Hon Hai Precision
$7.32 /

-0.12 (-1.61%)

GS Goldman Sachs
$339.09 /

-6.475 (-1.87%)

GM General Motors
$43.62 /

-1.195 (-2.67%)

DUOL Duolingo
$89.73 /

+0.65 (+0.73%)

CVX Chevron
$164.64 /

+4.03 (+2.51%)

COIN Coinbase
$176.78 /

-9.03 (-4.86%)

CHKP Check Point
$136.81 /

-3.41 (-2.43%)

BRK.A Berkshire Hathaway
$524,185.00 /

+11525 (+2.25%)

BA Boeing
$185.97 /

-6.94 (-3.60%)

ALNA Allena Pharmaceuticals
/

+

VLTA Volta
$4.12 /

-0.35 (-7.83%)

PLAN Acquired by Thoma Bravo 6/22
$64.60 /

+13.99 (+27.64%)

PDD Pinduoduo
$39.93 /

-2.61 (-6.14%)

OXY Occidental Petroleum
$60.96 /

+4.72 (+8.39%)

NLSN Nielsen
$22.75 /

-1.69 (-6.91%)

KSS Kohl's
$61.99 /

-0.43 (-0.69%)

GS Goldman Sachs
$339.09 /

-6.475 (-1.87%)

GM General Motors
$43.62 /

-1.195 (-2.67%)

GEVO Gevo
$4.59 /

+0.28 (+6.50%)

CVX Chevron
$164.64 /

+4.03 (+2.51%)

COIN Coinbase
$176.78 /

-9.03 (-4.86%)

BA Boeing
$185.97 /

-6.94 (-3.60%)

AMZN Amazon.com
$3,230.56 /

+1.98 (+0.06%)

Downgrade
Allena Pharmaceuticals downgraded to Neutral from Buy at B. Riley » 16:17
03/21/22
03/21
16:17
03/21/22
16:17
ALNA

Allena Pharmaceuticals

$0.28 /

-0.2088 (-43.16%)

B. Riley analyst Mayank…

B. Riley analyst Mayank Mamtani downgraded Allena Pharmaceuticals to Neutral from Buy with a 50c price target.

ShowHide Related Items >><<
ALNA Allena Pharmaceuticals
$0.28 /

-0.2088 (-43.16%)

ALNA Allena Pharmaceuticals
$0.28 /

-0.2088 (-43.16%)

03/21/22 H.C. Wainwright
H.C. Wainwright downgrades Allena on reloxaliase discontinuation
03/21/22 H.C. Wainwright
Allena Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
03/21/22 Ladenburg
Allena Pharmaceuticals downgraded to Neutral from Buy at Ladenburg
01/24/22 B. Riley
Allena Pharmaceuticals price target lowered to $3 from $4 at B. Riley
ALNA Allena Pharmaceuticals
$0.28 /

-0.2088 (-43.16%)

ALNA Allena Pharmaceuticals
$0.28 /

-0.2088 (-43.16%)

On The Fly
What You Missed On Wall Street This Morning » 12:17
03/21/22
03/21
12:17
03/21/22
12:17
PLAN

Acquired by Thoma Bravo 6/22

$64.59 /

+13.98 (+27.62%)

, BRK.A

Berkshire Hathaway

$523,000.00 /

+10340 (+2.02%)

, BRK.B

Berkshire Hathaway

$348.80 /

+6.415 (+1.87%)

, Y

Alleghany

$844.25 /

+172.75 (+25.73%)

, NLSN

Nielsen

$22.46 /

-1.98 (-8.10%)

, GM

General Motors

$43.58 /

-1.24 (-2.77%)

, SFTBY

SoftBank Group

$21.68 /

+1.51 (+7.49%)

, KSS

Kohl's

$62.07 /

-0.35 (-0.56%)

, OXY

Occidental Petroleum

$60.90 /

+4.66 (+8.29%)

, KOS

Kosmos

$6.48 /

+0.07 (+1.09%)

, ALNA

Allena Pharmaceuticals

/

+

, GEVO

Gevo

$4.62 /

+0.315 (+7.32%)

, COIN

Coinbase

$178.00 /

-7.81 (-4.20%)

, VLTA

Volta

$4.21 /

-0.26 (-5.82%)

, IMGN

ImmunoGen

$4.24 /

-1.01 (-19.24%)

, CHKP

Check Point

$137.10 /

-3.12 (-2.23%)

, DUOL

Duolingo

$91.95 /

+2.87 (+3.22%)

, IAS

Integral Ad Science

$16.05 /

+1.485 (+10.20%)

, DDL

Dingdong

$3.55 /

-0.18 (-4.83%)

, BA

Boeing

$185.21 /

-7.7 (-3.99%)

, HNHPF

Hon Hai Precision

$7.44 /

+0.17 (+2.34%)

, FB

Ticker changed to META

$211.85 /

-4.92 (-2.27%)

, CVX

Chevron

$163.50 /

+2.89 (+1.80%)

, AMZN

Amazon.com

$3,246.44 /

+17.86 (+0.55%)

, PDD

Pinduoduo

$39.68 /

-2.86 (-6.72%)

, GRPH

Graphite Bio

$6.92 /

-1.29 (-15.71%)

, URGN

UroGen Pharma

$9.29 /

+0.32 (+3.57%)

, CLRB

Cellectar Biosciences

/

+

, MRNS

Marinus Pharmaceuticals

$8.85 /

-1.13 (-11.32%)

, CEA

China Eastern Airlines

$17.89 /

-1.02 (-5.39%)

Get caught up quickly on…

ShowHide Related Items >><<
Y Alleghany
$844.25 /

+172.75 (+25.73%)

VLTA Volta
$4.21 /

-0.26 (-5.82%)

URGN UroGen Pharma
$9.29 /

+0.32 (+3.57%)

SFTBY SoftBank Group
$21.68 /

+1.51 (+7.49%)

PLAN Acquired by Thoma Bravo 6/22
$64.59 /

+13.98 (+27.62%)

PDD Pinduoduo
$39.68 /

-2.86 (-6.72%)

OXY Occidental Petroleum
$60.90 /

+4.66 (+8.29%)

NLSN Nielsen
$22.46 /

-1.98 (-8.10%)

MRNS Marinus Pharmaceuticals
$8.85 /

-1.13 (-11.32%)

KSS Kohl's
$62.07 /

-0.35 (-0.56%)

KOS Kosmos
$6.48 /

+0.07 (+1.09%)

IMGN ImmunoGen
$4.24 /

-1.01 (-19.24%)

IAS Integral Ad Science
$16.05 /

+1.485 (+10.20%)

HNHPF Hon Hai Precision
$7.44 /

+0.17 (+2.34%)

GRPH Graphite Bio
$6.92 /

-1.29 (-15.71%)

GM General Motors
$43.58 /

-1.24 (-2.77%)

GEVO Gevo
$4.62 /

+0.315 (+7.32%)

FB Ticker changed to META
$211.85 /

-4.92 (-2.27%)

DUOL Duolingo
$91.95 /

+2.87 (+3.22%)

DDL Dingdong
$3.55 /

-0.18 (-4.83%)

CVX Chevron
$163.50 /

+2.89 (+1.80%)

COIN Coinbase
$178.00 /

-7.81 (-4.20%)

CLRB Cellectar Biosciences
/

+

CHKP Check Point
$137.10 /

-3.12 (-2.23%)

CEA China Eastern Airlines
$17.89 /

-1.02 (-5.39%)

BRK.B Berkshire Hathaway
$348.80 /

+6.415 (+1.87%)

BRK.A Berkshire Hathaway
$523,000.00 /

+10340 (+2.02%)

BA Boeing
$185.21 /

-7.7 (-3.99%)

AMZN Amazon.com
$3,246.44 /

+17.86 (+0.55%)

ALNA Allena Pharmaceuticals
/

+

PLAN Acquired by Thoma Bravo 6/22
$64.59 /

+13.98 (+27.62%)

03/21/22 BMO Capital
Anaplan price target raised to $66 from $55 at BMO Capital
03/21/22 William Blair
Anaplan downgraded to Market Perform from Outperform at William Blair
03/21/22 Wolfe Research
Anaplan downgraded to Peer Perform from Outperform at Wolfe Research
03/21/22 Needham
Anaplan downgraded to Hold from Buy at Needham
BRK.A Berkshire Hathaway
$523,000.00 /

+10340 (+2.02%)

03/21/22 Keefe Bruyette
Alleghany complexity makes other bids unlikely, says Keefe Bruyette
11/07/21 Keefe Bruyette
Berkshire Q3 missed 'virtually across the board,' says Keefe Bruyette
09/07/21 Wells Fargo
Kroger price target raised to $46 from $39 at Wells Fargo
06/24/21 Gordon Haskett
Hershey jet found recently in Omaha, says Gordon Haskett
BRK.B Berkshire Hathaway
$348.80 /

+6.415 (+1.87%)

08/09/21 UBS
Berkshire Hathaway price target raised to $329 from $319 at UBS
Y Alleghany
$844.25 /

+172.75 (+25.73%)

03/20/22 Keefe Bruyette
Alleghany initiated with an Outperform at Keefe Bruyette
08/06/21 Deutsche Bank
Alleghany price target raised to $915 from $890 at Deutsche Bank
05/07/21 Deutsche Bank
Alleghany price target raised to $890 from $825 at Deutsche Bank
NLSN Nielsen
$22.46 /

-1.98 (-8.10%)

03/15/22 Baird
Nielsen price target raised to $25 from $20 at Baird
03/08/22 Citi
Nielsen price target lowered to $19 from $21 at Citi
01/27/22 Truist
Truist downgrades Nielsen on competition in TV measurement
01/27/22 Truist
Nielsen downgraded to Hold from Buy at Truist
GM General Motors
$43.58 /

-1.24 (-2.77%)

03/21/22 Morgan Stanley
General Motors' EV/AV valuation cut by 'nearly half' at Morgan Stanley
03/21/22 Wolfe Research
General Motors price target raised to $70 from $67 at Wolfe Research
03/16/22 Craig-Hallum
Craig-Hallum starts 'lidar's new leader' Cepton at Buy
03/15/22 Jefferies
General Motors price target lowered to $44 from $53 at Jefferies
SFTBY SoftBank Group
$21.68 /

+1.51 (+7.49%)

02/08/22 Citi
Street largely expected Nvidia deal to fall through, says Citi
02/07/22 Citi
Alibaba filing may suggest Softbank intention to sell shares, says Citi
07/21/21 JPMorgan
SoftBank Group assumed with an Overweight at JPMorgan
06/08/21 Jefferies
SoftBank upgraded to Buy from Hold at Jefferies
KSS Kohl's
$62.07 /

-0.35 (-0.56%)

03/08/22 Credit Suisse
Kohl's price target lowered to $60 from $70 at Credit Suisse
03/08/22 Citi
Kohl's investors wanted to hear more about sale, says Citi
03/08/22 BofA
Kohl's reinstated with a Neutral at BofA
03/02/22 Baird
Kohl's price target lowered to $68 from $75 at Baird
OXY Occidental Petroleum
$60.90 /

+4.66 (+8.29%)

03/18/22 Barclays
Occidental Petroleum price target raised to $69 from $44 at Barclays
03/14/22 Morgan Stanley
Occidental Petroleum downgraded to Equal Weight at Morgan Stanley after doubling
03/14/22 Morgan Stanley
Occidental downgraded to Equal Weight from Overweight at Morgan Stanley
03/11/22 Truist
Occidental Petroleum price target raised to $75 from $58 at Truist
KOS Kosmos
$6.48 /

+0.07 (+1.09%)

11/11/21 Barclays
Kosmos upgraded to Overweight from Equal Weight at Barclays
10/15/21 Berenberg
Kosmos upgraded to Buy from Hold at Berenberg
06/21/21 Bernstein
Kosmos upgraded to Outperform from Market Perform at Bernstein
06/08/21 Johnson Rice
Kosmos upgraded to Buy from Accumulate at Johnson Rice
ALNA Allena Pharmaceuticals
/

+

03/21/22 H.C. Wainwright
H.C. Wainwright downgrades Allena on reloxaliase discontinuation
03/21/22 H.C. Wainwright
Allena Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
03/21/22 Ladenburg
Allena Pharmaceuticals downgraded to Neutral from Buy at Ladenburg
01/24/22 B. Riley
Allena Pharmaceuticals price target lowered to $3 from $4 at B. Riley
GEVO Gevo
$4.62 /

+0.315 (+7.32%)

02/09/22 Citi
Gevo initiated with a Buy at Citi
08/23/21 Stifel
Gevo initiated with a Buy, $10 price target at Stifel
08/23/21 Stifel
Gevo initiated with a Buy at Stifel
COIN Coinbase
$178.00 /

-7.81 (-4.20%)

02/28/22 Compass Point
Coinbase price target lowered to $200 from $325 at Compass Point
02/25/22 Needham
Coinbase price target lowered to $360 from $420 at Needham
02/25/22 Canaccord
Coinbase price target lowered to $275 from $342 at Canaccord
02/25/22 DA Davidson
Coinbase price target lowered to $225 from $275 at DA Davidson
VLTA Volta
$4.21 /

-0.26 (-5.82%)

02/01/22 Canaccord
Volta initiated with a Buy, $10 target at Canaccord
02/01/22 Canaccord
Volta initiated with a Buy at Canaccord
12/15/21 Goldman Sachs
Volta initiated with a Neutral at Goldman Sachs
12/14/21 Cantor Fitzgerald
Cantor starts Volta at Overweight with $13 price target
IMGN ImmunoGen
$4.24 /

-1.01 (-19.24%)

03/21/22 RBC Capital
ImmunoGen downgraded to Sector Perform from Outperform at RBC Capital
02/10/22 BMO Capital
ImmunoGen initiated with an Outperform at BMO Capital
01/03/22 Guggenheim
ImmunoGen, Merus named 'Best Ideas' in oncology-focused biotech at Guggenheim
12/01/21 Jefferies
ImmunoGen upgraded to Buy at Jefferies after 'best-case data' in PROC
CHKP Check Point
$137.10 /

-3.12 (-2.23%)

03/21/22 Piper Sandler
Check Point downgraded to Underweight from Neutral at Piper Sandler
03/17/22 Deutsche Bank
Check Point price target raised to $160 from $154 at Deutsche Bank
03/10/22 Cowen
Check Point price target raised to $164 from $142 at Cowen
02/16/22 BMO Capital
Check Point upgraded to Outperform from Market Perform at BMO Capital
DUOL Duolingo
$91.95 /

+2.87 (+3.22%)

03/21/22 KeyBanc
KeyBanc upgrades Duolingo to Overweight with $112 price target
03/21/22 KeyBanc
Duolingo upgraded to Overweight from Sector Weight at KeyBanc
03/15/22 Evercore ISI
Duolingo, XPO Logistics added to 'Best SMID 'Core' Ideas' list at Evercore ISI
03/04/22 Evercore ISI
Duolingo removed from 'Tactical Outperform' list, target cut to $120 at Evercore
IAS Integral Ad Science
$16.05 /

+1.485 (+10.20%)

03/21/22 Raymond James
Integral Ad Science upgraded at Raymond James amid 'unjustified' selloff
03/21/22 Raymond James
Integral Ad Science upgraded to Strong Buy from Outperform at Raymond James
03/17/22 Barclays
Barclays says Meta opening up feed positive for DoubleVerify, Integral Ad
03/04/22 Barclays
Integral Ad Science price target lowered to $20 from $23 at Barclays
DDL Dingdong
$3.55 /

-0.18 (-4.83%)

03/21/22 Morgan Stanley
Dingdong downgraded to Underweight from Overweight at Morgan Stanley
03/14/22 JPMorgan
JPMorgan downgrades Dada Nexus to Neutral, prefers over smaller peer Dingdong
03/14/22 JPMorgan
Dingdong price target lowered to $2.50 from $21 at JPMorgan
11/19/21 JPMorgan
Dingdong initiated with an Underweight at JPMorgan
BA Boeing
$185.21 /

-7.7 (-3.99%)

03/21/22 JPMorgan
Chinese government response to 737 crash critical for Boeing, says JPMorgan
03/16/22 Baird
Boeing elevated to Bullish Fresh Pick at Baird
03/09/22
Boeing initiated with a Buy rating at Langenberg
03/07/22 Cowen
Boeing price target lowered to $230 from $265 at Cowen
HNHPF Hon Hai Precision
$7.44 /

+0.17 (+2.34%)

03/14/22 BofA
Apple exposure to Shenzhen and Suzhou 'manageable,' says BofA
11/12/21 R.F. Lafferty
R.F. Lafferty upgrades Lordstown to Hold on better odds for Endurance production
FB Ticker changed to META
$211.85 /

-4.92 (-2.27%)

03/15/22 Cleveland Research
Snap Q1 estimates raised at Cleveland Research
03/10/22 Deutsche Bank
Meta Platforms initiated with a Buy at Deutsche Bank
03/08/22 JPMorgan
Russia invasion brings 'new set of risks' for internet sector, says JPMorgan
CVX Chevron
$163.50 /

+2.89 (+1.80%)

03/14/22 Morgan Stanley
Chevron downgraded to Equal Weight at Morgan Stanley after outperformance
03/14/22 Morgan Stanley
Chevron downgraded to Equal Weight from Overweight at Morgan Stanley
03/11/22 JPMorgan
Chevron downgraded to Underweight from Neutral at JPMorgan
03/09/22 Barclays
Chevron price target raised to $183 from $148 at Barclays
AMZN Amazon.com
$3,246.44 /

+17.86 (+0.55%)

03/21/22 CL King
SpartanNash initiated with a Neutral at CL King
03/16/22 Needham
Needham says Netflix needs ads as streamers turn to news, sports
03/15/22 BWS Financial
BWS drops coverage of PLx Pharma, says off Amazon again
03/10/22 Deutsche Bank
Amazon.com initiated with a Buy at Deutsche Bank
PDD Pinduoduo
$39.68 /

-2.86 (-6.72%)

03/16/22 US Tiger
China Internet sector upgraded to Outperform from Neutral at US Tiger
03/14/22 JPMorgan
Pinduoduo downgraded to Underweight from Overweight at JPMorgan
02/16/22 Citi
Pinduoduo upgraded to Buy from Neutral at Citi
01/14/22 DBS Bank
Pinduoduo upgraded to Buy from Hold at DBS Bank
GRPH Graphite Bio
$6.92 /

-1.29 (-15.71%)

02/17/22 RBC Capital
RBC starts Graphite Bio at Sector Perform, sees limited conviction on lead asset
02/17/22 RBC Capital
Graphite Bio initiated with a Sector Perform at RBC Capital
07/20/21 Cowen
Cowen starts Graphite Bio at Outperform, sees long-term value
07/20/21 Morgan Stanley
Graphite Bio initiated with an Overweight at Morgan Stanley
URGN UroGen Pharma
$9.29 /

+0.32 (+3.57%)

01/18/22 H.C. Wainwright
UroGen Pharma price target lowered to $34 from $50 at H.C. Wainwright
04/27/21 H.C. Wainwright
UroGen Pharma price target lowered to $50 from $57 at H.C. Wainwright
CLRB Cellectar Biosciences
/

+

08/16/21 Roth Capital
Roth Capital views Cellectar Biosciences as 'grossly undervalued'
06/04/21 Roth Capital
Cellectar Biosciences' Phase 2a results 'highly positive,' says Roth Capital
04/27/21 Roth Capital
Cellectar strengthens IP estate as CLR 131 trial progresses, says Roth Capital
MRNS Marinus Pharmaceuticals
$8.85 /

-1.13 (-11.32%)

02/23/22 Truist
Marinus Pharmaceuticals price target lowered to $35 from $40 at Truist
08/18/21 Truist
Marinus Pharmaceuticals price target raised to $40 from $35 at Truist
CEA China Eastern Airlines
$17.89 /

-1.02 (-5.39%)

03/15/22 Credit Suisse
China Eastern Airlines downgraded to Underperform from Neutral at Credit Suisse
02/08/22 Goldman Sachs
China Eastern Airlines initiated with a Buy at Goldman Sachs
11/29/21 JPMorgan
China Eastern Airlines downgraded to Neutral from Overweight at JPMorgan
07/30/21 JPMorgan
China Eastern Airlines downgraded to Neutral from Overweight at JPMorgan
Y Alleghany
$844.25 /

+172.75 (+25.73%)

VLTA Volta
$4.21 /

-0.26 (-5.82%)

URGN UroGen Pharma
$9.29 /

+0.32 (+3.57%)

PLAN Acquired by Thoma Bravo 6/22
$64.59 /

+13.98 (+27.62%)

PDD Pinduoduo
$39.68 /

-2.86 (-6.72%)

OXY Occidental Petroleum
$60.90 /

+4.66 (+8.29%)

NLSN Nielsen
$22.46 /

-1.98 (-8.10%)

MRNS Marinus Pharmaceuticals
$8.85 /

-1.13 (-11.32%)

KSS Kohl's
$62.07 /

-0.35 (-0.56%)

IMGN ImmunoGen
$4.24 /

-1.01 (-19.24%)

IAS Integral Ad Science
$16.05 /

+1.485 (+10.20%)

GRPH Graphite Bio
$6.92 /

-1.29 (-15.71%)

GM General Motors
$43.58 /

-1.24 (-2.77%)

GEVO Gevo
$4.62 /

+0.315 (+7.32%)

FB Ticker changed to META
$211.85 /

-4.92 (-2.27%)

DUOL Duolingo
$91.95 /

+2.87 (+3.22%)

CVX Chevron
$163.50 /

+2.89 (+1.80%)

COIN Coinbase
$178.00 /

-7.81 (-4.20%)

CLRB Cellectar Biosciences
/

+

CHKP Check Point
$137.10 /

-3.12 (-2.23%)

BRK.A Berkshire Hathaway
$523,000.00 /

+10340 (+2.02%)

BA Boeing
$185.21 /

-7.7 (-3.99%)

AMZN Amazon.com
$3,246.44 /

+17.86 (+0.55%)

ALNA Allena Pharmaceuticals
/

+

  • 02
    Dec
  • 15
    Oct
  • 28
    Jul
  • 29
    Jun
  • 30
    Jun
  • 25
    Jun
  • 14
    Apr
VLTA Volta
$4.21 /

-0.26 (-5.82%)

SFTBY SoftBank Group
$21.68 /

+1.51 (+7.49%)

PLAN Acquired by Thoma Bravo 6/22
$64.59 /

+13.98 (+27.62%)

PDD Pinduoduo
$39.68 /

-2.86 (-6.72%)

OXY Occidental Petroleum
$60.90 /

+4.66 (+8.29%)

NLSN Nielsen
$22.46 /

-1.98 (-8.10%)

KSS Kohl's
$62.07 /

-0.35 (-0.56%)

HNHPF Hon Hai Precision
$7.44 /

+0.17 (+2.34%)

GM General Motors
$43.58 /

-1.24 (-2.77%)

GEVO Gevo
$4.62 /

+0.315 (+7.32%)

FB Ticker changed to META
$211.85 /

-4.92 (-2.27%)

DDL Dingdong
$3.55 /

-0.18 (-4.83%)

CVX Chevron
$163.50 /

+2.89 (+1.80%)

COIN Coinbase
$178.00 /

-7.81 (-4.20%)

CHKP Check Point
$137.10 /

-3.12 (-2.23%)

BRK.B Berkshire Hathaway
$348.80 /

+6.415 (+1.87%)

BRK.A Berkshire Hathaway
$523,000.00 /

+10340 (+2.02%)

BA Boeing
$185.21 /

-7.7 (-3.99%)

AMZN Amazon.com
$3,246.44 /

+17.86 (+0.55%)

VLTA Volta
$4.21 /

-0.26 (-5.82%)

SFTBY SoftBank Group
$21.68 /

+1.51 (+7.49%)

PLAN Acquired by Thoma Bravo 6/22
$64.59 /

+13.98 (+27.62%)

PDD Pinduoduo
$39.68 /

-2.86 (-6.72%)

OXY Occidental Petroleum
$60.90 /

+4.66 (+8.29%)

NLSN Nielsen
$22.46 /

-1.98 (-8.10%)

KSS Kohl's
$62.07 /

-0.35 (-0.56%)

KOS Kosmos
$6.48 /

+0.07 (+1.09%)

IMGN ImmunoGen
$4.24 /

-1.01 (-19.24%)

HNHPF Hon Hai Precision
$7.44 /

+0.17 (+2.34%)

GM General Motors
$43.58 /

-1.24 (-2.77%)

FB Ticker changed to META
$211.85 /

-4.92 (-2.27%)

DUOL Duolingo
$91.95 /

+2.87 (+3.22%)

CVX Chevron
$163.50 /

+2.89 (+1.80%)

COIN Coinbase
$178.00 /

-7.81 (-4.20%)

CHKP Check Point
$137.10 /

-3.12 (-2.23%)

BRK.A Berkshire Hathaway
$523,000.00 /

+10340 (+2.02%)

BA Boeing
$185.21 /

-7.7 (-3.99%)

ALNA Allena Pharmaceuticals
/

+

VLTA Volta
$4.21 /

-0.26 (-5.82%)

SFTBY SoftBank Group
$21.68 /

+1.51 (+7.49%)

PLAN Acquired by Thoma Bravo 6/22
$64.59 /

+13.98 (+27.62%)

PDD Pinduoduo
$39.68 /

-2.86 (-6.72%)

OXY Occidental Petroleum
$60.90 /

+4.66 (+8.29%)

NLSN Nielsen
$22.46 /

-1.98 (-8.10%)

KSS Kohl's
$62.07 /

-0.35 (-0.56%)

GM General Motors
$43.58 /

-1.24 (-2.77%)

GEVO Gevo
$4.62 /

+0.315 (+7.32%)

FB Ticker changed to META
$211.85 /

-4.92 (-2.27%)

CVX Chevron
$163.50 /

+2.89 (+1.80%)

COIN Coinbase
$178.00 /

-7.81 (-4.20%)

BA Boeing
$185.21 /

-7.7 (-3.99%)

AMZN Amazon.com
$3,246.44 /

+17.86 (+0.55%)

Downgrade
H.C. Wainwright downgrades Allena on reloxaliase discontinuation » 11:23
03/21/22
03/21
11:23
03/21/22
11:23
ALNA

Allena Pharmaceuticals

/

+

H.C. Wainwright analyst…

H.C. Wainwright analyst Edward White downgraded Allena Pharmaceuticals to Neutral from Buy without a price target after the company discontinued its reloxaliase program. The analyst said he will review his rating once seeing the Phase 2 clinical data for ALLN-346 or when a strategic alternative is announced. White downgraded Allena after removing reloxaliase from the stock's valuation. Allena shares are down 36% to 31c in late morning trading.

ShowHide Related Items >><<
ALNA Allena Pharmaceuticals
/

+

ALNA Allena Pharmaceuticals
/

+

03/21/22 H.C. Wainwright
Allena Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
03/21/22 Ladenburg
Allena Pharmaceuticals downgraded to Neutral from Buy at Ladenburg
01/24/22 B. Riley
Allena Pharmaceuticals price target lowered to $3 from $4 at B. Riley
08/18/21 B. Riley
Allena Pharmaceuticals price target lowered to $4 from $5 at B. Riley
ALNA Allena Pharmaceuticals
/

+

ALNA Allena Pharmaceuticals
/

+

Downgrade
Allena Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright » 11:17
03/21/22
03/21
11:17
03/21/22
11:17
ALNA

Allena Pharmaceuticals

/

+

H.C. Wainwright analyst…

H.C. Wainwright analyst Edward White downgraded Allena Pharmaceuticals to Neutral from Buy without a price target.

ShowHide Related Items >><<
ALNA Allena Pharmaceuticals
/

+

ALNA Allena Pharmaceuticals
/

+

03/21/22 Ladenburg
Allena Pharmaceuticals downgraded to Neutral from Buy at Ladenburg
01/24/22 B. Riley
Allena Pharmaceuticals price target lowered to $3 from $4 at B. Riley
08/18/21 B. Riley
Allena Pharmaceuticals price target lowered to $4 from $5 at B. Riley
08/11/21 H.C. Wainwright
Allena Pharmaceuticals price target raised to $11 from $10 at H.C. Wainwright
ALNA Allena Pharmaceuticals
/

+

ALNA Allena Pharmaceuticals
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.